The performance of European countries in biotechnology: how does Europe compare to the USA? Online publication date: Wed, 16-Jul-2008
by Thomas Reiss, Iciar Dominguez Lacasa
International Journal of Biotechnology (IJBT), Vol. 10, No. 4, 2008
Abstract: This paper presents an analysis of the performance of the European Union (EU) member states and the USA in biotechnology based on various science, technology and commercialisation indicators. The performance analysis shows that European countries can be grouped into three clusters: Cluster 1, with the best-performing countries, includes Switzerland, Denmark, Sweden and Finland. Cluster 2 performs at a level that is roughly similar to the European median and includes Austria, Belgium, the Netherlands, Ireland, Norway, Germany, France and the UK. Cluster 3 – Italy, Greece, Spain, Portugal and Luxembourg – performs well below the European median. The best-performing European countries achieve higher performance scores than the USA. Within the whole spectrum of the considered European countries, the USA would be positioned in the first half. The comparison of the scientific and commercialisation performance of the individual countries reveals clear evidence for a positive correlation between scientific and commercial performance.
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Biotechnology (IJBT):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email subs@inderscience.com
Our Blog 
Follow us on Twitter 
Visit us on Facebook